VSV infection and LPS treatment alter serum bile acid profiles, bile acid biosynthesis, and bile acid receptors in mice

被引:0
|
作者
Li, Yamei [1 ,2 ]
Luo, Yan [3 ]
Wang, Chao [3 ]
Xu, Lei [3 ]
Dai, Xinhua [1 ,2 ]
An, Yunfei [1 ,2 ]
He, Lin [3 ]
Zeng, Dongmei [3 ]
Bai, Yangjuan [1 ,2 ]
Zhang, Hua [3 ,4 ]
机构
[1] Sichuan Univ, West China Hosp, Med Res Ctr, Dept Lab Med,Clin Lab, Chengdu, Sichuan, Peoples R China
[2] Sichuan Clin Res Ctr Lab Med, Chengdu, Sichuan, Peoples R China
[3] Gen Hosp Western Theater Command, Dept Pathol, Chengdu, Sichuan, Peoples R China
[4] Gen Hosp Western Theater Command, Pancreat Injury & Repair Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China
来源
MICROBIOLOGY SPECTRUM | 2024年 / 12卷 / 11期
基金
中国国家自然科学基金;
关键词
VSV infection; LPS treatment; bile acid profiles; bile acid biosynthesis; bile acid receptors; HEPATITIS-B-VIRUS; VIRAL ENTRY; PHYSIOLOGY; EXPRESSION;
D O I
10.1128/spectrum.00836-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pathogen infections remain a significant public health problem worldwide. Accumulating evidence regarding the crosstalk between bile acid (BA) metabolism and immune response reveals that BA metabolism regulates host immunity and microbial pathogenesis, making it an attractive target for disease prevention and infection control. However, the effect of infection on circulating BA profiles, the biosynthesis-related enzymes, and their receptors remains to be depicted. Here, we investigated the effect of viral (vesicular stomatitis virus, VSV) and bacterial (lipopolysaccharide, LPS) infections on BA metabolism and signaling. Infection models were successfully established by intraperitoneally injecting VSV and LPS, respectively. VSV and LPS injection significantly changed the circulating BA profiles, with highly increased levels of taurine-conjugated BAs and significant decreases in unconjugated BAs. Consistent with the decreased levels of circulating cholic acid (CA) and chenodeoxycholic acid (CDCA), the expression of BA biosynthesis-related rate-limiting enzymes (Cyp7a1, Cyp27a1, Cyp8b1, and Hsd3b7) were significantly reduced. Furthermore, hepatic and pulmonary BA receptors (BARs) expression varied in different infection models. LPS treatment had an extensive impact on tested hepatic and pulmonary BARs, resulting in the upregulation of TGR5, S1PR2, and VDR, while VSV infection only promoted VDR expression. Our study provides insights into the involvement of BA metabolism in the pathophysiology of infection, which may provide potential clues for targeting BA metabolism and BAR signaling to boost innate immunity and control infection.IMPORTANCEThis study focuses on the crosstalk between bile acid (BA) metabolism and immune response in VSV infection and LPS treatment models and depicts the effect of infection on circulating BA profiles, the biosynthesis-related enzymes, and their receptors. These findings provide insights into the effect of infection on BA metabolism and signaling, adding a more comprehensive understanding to the relationship between infection, BA metabolism and immune responses. This study focuses on the crosstalk between bile acid (BA) metabolism and immune response in VSV infection and LPS treatment models and depicts the effect of infection on circulating BA profiles, the biosynthesis-related enzymes, and their receptors. These findings provide insights into the effect of infection on BA metabolism and signaling, adding a more comprehensive understanding to the relationship between infection, BA metabolism and immune responses.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Glucocorticoid treatment alters systemic bile acid homeostasis by regulating the biosynthesis and transport of bile salts
    Xiao, Yongtao
    Yan, Weihui
    Zhou, Kejun
    Cao, Yi
    Cai, Wei
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (07) : 771 - 779
  • [32] HYOCHOLIC ACID, A TRIHYDROXY BILE ACID FROM PIG BILE
    HASLEWOOD, GAD
    BIOCHEMICAL JOURNAL, 1954, 56 (04) : R38 - R38
  • [33] The impact of treatment with bile acid sequestrants on quality of life in patients with bile acid diarrhoea
    Aditi Kumar
    Niall Galbraith
    Hafid O. Al-Hassi
    Manushri Jain
    Oliver Phipps
    Jeffrey Butterworth
    Helen Steed
    John McLaughlin
    Matthew J. Brookes
    BMC Gastroenterology, 22
  • [34] Bile Acid Sulfation: A Pathway of Bile Acid Elimination and Detoxification
    Alnouti, Yazen
    TOXICOLOGICAL SCIENCES, 2009, 108 (02) : 225 - 246
  • [35] EVIDENCE FOR COORDINATE REGULATION OF BILE-ACID BIOSYNTHESIS BY 2 BILE-ACID RESPONSIVE ENZYMES
    JAIRATH, SK
    PANDAK, WM
    HEUMAN, DM
    MILLER, A
    HYLEMON, PB
    VLAHCEVIC, ZR
    GASTROENTEROLOGY, 1994, 106 (04) : A911 - A911
  • [36] SERUM BILE-ACID ANALYSIS
    SETCHELL, KDR
    MATSUI, A
    CLINICA CHIMICA ACTA, 1983, 127 (01) : 1 - 17
  • [37] Docosahexaenoic acid activates bile acid detoxification in mice
    Cieslak, Anna
    Trottier, Jocelyn
    Verreault, Melanie
    Calon, Frederic
    Vohl, Marie-Claude
    Milkiewicz, Piotr
    Barbier, Olivier
    DRUG METABOLISM REVIEWS, 2016, 48 : 93 - 94
  • [38] ODEVIXIBAT TREATMENT IN RESPONSIVE PATIENTS WITH BILE SALT EXPORT PUMP DEFICIENCY RESTORES BILIARY BILE ACID SECRETION, AS INDICATED BY SERUM BILE ACID COMPOSITION
    Nomden, Mark
    Verkade, Henkjan J.
    Kuipers, Folkert
    Yu, Qifeng
    Mattsson, Jan P.
    Lindstrom, Erik
    Valcheva, Velichka
    HEPATOLOGY, 2023, 77 (05) : E120 - E120
  • [39] PREDICTION OF THE BILE-ACID COMPOSITION OF BILE FROM SERUM BILE-ACID ANALYSIS DURING GALLSTONE DISSOLUTION THERAPY
    WHITING, MJ
    WATTS, JM
    GASTROENTEROLOGY, 1980, 78 (02) : 220 - 225
  • [40] SERUM BILE-ACID DETERMINATION THROUGH BIOLUMINESCENCE ASSAYS FOR 3-ALPHA-BILE ACID, 7-ALPHA-BILE ACID AND 12-ALPHA-BILE ACIDS
    SCHOLMERICH, J
    HOFMANN, AF
    DELUCA, M
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1983, 21 (08): : 469 - 470